An immune effector cell is a cell that can create an immune response within the body. These cells can be used to treat diseases. This information is for clinicians, patients, carers and the general community on immune effector cells.
In NSW, immune effector cell treatments are either available for commercial use following approval from the Therapeutic Goods Administration or under a clinical trial. For further information, you can learn about therapy including short and long term risks and side effects and talk to your treating CAR T-cell medical team.
Working across NSW Health to implement CAR T-cell therapies
The ACI works in partnership with clinicians of the Translational Immune Effector Cell Working Group, the Ministry of Health and eviQ in implementing CAR T-cell therapies in NSW.